BetterLife Financial Statements From 2010 to 2024
| BETRF Stock | USD 0.08 0.01 9.59% |
Check BetterLife Pharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among BetterLife Pharma's main balance sheet or income statement drivers, such as , as well as many indicators such as . BetterLife financial statements analysis is a perfect complement when working with BetterLife Pharma Valuation or Volatility modules.
BetterLife |
BetterLife Pharma OTC Stock Shares Outstanding Analysis
BetterLife Pharma's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current BetterLife Pharma Shares Outstanding | 90.1 M |
Most of BetterLife Pharma's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, BetterLife Pharma is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
Based on the latest financial disclosure, BetterLife Pharma has 90.1 M of shares currently outstending. This is 50.09% lower than that of the Healthcare sector and 15.68% lower than that of the Biotechnology industry. The shares outstanding for all United States stocks is 84.24% higher than that of the company.
BetterLife Pharma Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining BetterLife Pharma's current stock value. Our valuation model uses many indicators to compare BetterLife Pharma value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across BetterLife Pharma competition to find correlations between indicators driving BetterLife Pharma's intrinsic value. More Info.BetterLife Pharma is rated below average in return on equity category among its peers. It is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the BetterLife Pharma's earnings, one of the primary drivers of an investment's value.About BetterLife Pharma Financial Statements
BetterLife Pharma stakeholders use historical fundamental indicators, such as BetterLife Pharma's revenue or net income, to determine how well the company is positioned to perform in the future. Although BetterLife Pharma investors may analyze each financial statement separately, they are all interrelated. For example, changes in BetterLife Pharma's assets and liabilities are reflected in the revenues and expenses on BetterLife Pharma's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in BetterLife Pharma. Please read more on our technical analysis and fundamental analysis pages.
BetterLife Pharma Inc., a biotechnology company, engages in the development and commercialization of compounds for the treatment of neurological disorders in Canada and internationally. BetterLife Pharma Inc. was incorporated in 2002 and is headquartered in Vancouver, Canada. Betterlife Pharma operates under Biotechnology classification in the United States and is traded on OTC Exchange.
Currently Active Assets on Macroaxis
Other Information on Investing in BetterLife OTC Stock
BetterLife Pharma financial ratios help investors to determine whether BetterLife OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BetterLife with respect to the benefits of owning BetterLife Pharma security.